Omeros forms oncology committee to guide development of its AML therapy, which showed strong efficacy and safety in ...

OMER said it would resubmit a Biologics License Application in the U.S. for narsoplimab as soon as possible to position the drug as the first FDA-approved treatment option for TA-TMA. An EU ...

The drug has received breakthrough therapy and orphan drug designations from the FDA for TA-TMA and is pending approval for ...